Andrea Anampa-Guzmán
Andrea Anampa-Guzmán/X

Andrea Anampa-Guzmán: Honored to be Selected as a 2025–2026 FDA–AACR Oncology Educational Fellow

Andrea Anampa-Guzmán, NIH T32 Fellow in clinical pharmacology at Mayo Clinic, shared a post on LinkedIn:

“I am honored to share that I have been selected as a 2025–2026 FDA–AACR Oncology Educational Fellow. Over the next year, I will join an outstanding cohort of fellows to participate in virtual educational events covering a wide range of critical topics in oncology drug development and regulation—including INDs, NDAs/BLAs, expedited pathways, animal studies, clinical pharmacology, statistics, clinical trial design, companion diagnostics, biomarkers, and precision oncology. I am grateful to the American Association for Cancer Research and the FDA for this opportunity.”